Literature DB >> 21418302

Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.

Xu-hong Hou1, Yun-xia Zhu, Hui-juan Lu, Hui-fen Chen, Qiang Li, Shan Jiang, Kun-san Xiang, Wei-ping Jia.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is becoming a major public health hazard in China. The present study aimed to estimate the prevalence of NAFLD, NAFLD with abnormal serum alanine aminotransferase (ALT) levels, and determine the potential associations of ALT levels with the components of metabolic syndrome (MetS) in the absence or presence of NAFLD in Chinese adults.
METHODS: A population-based cross-sectional survey was conducted with 2226 participants. Physical examinations, laboratory tests and hepatic ultrasounds were performed. Individuals were further stratified into higher or lower ALT subgroups with the upper quartiles of ALT in this population. The MetS was identified according to the criteria of the Chinese Joint Committee for Developing Chinese Guidelines (JCDCG).
RESULTS: The standardized prevalence of NAFLD was 23.3% (NAFLD with abnormal ALT levels, 3.1%), 26.5% (NAFLD with abnormal ALT levels, 5.1%) in males, and 19.7% (NAFLD with abnormal ALT levels, 0.9%) in females. Multivariate logistic analysis revealed that higher ALT was significantly associated with elevated triglyceride (TG) in the non-NAFLD participants, independent of age, smoking status, drinking status, and other MetS-related measures with odds ratios (95% confidence intervals) of 3.4 (1.6-7.1) and 2.3 (1.4-3.7) in males and females, respectively. On the other hand, the higher ALT was statistically associated with elevated TG and hyperglycemia in the NAFLD cases with odds ratios of 2.2 to 2.5 (P<0.05).
CONCLUSIONS: The prevalence of NAFLD has become epidemic in Shanghai adults. NAFLD combined with ALT levels may be used to identify the individuals at the different risk levels of metabolic disorders.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418302     DOI: 10.1111/j.1440-1746.2010.06509.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

1.  Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Jie Xing; Xue Guan; Qian Zhang; Shuohua Chen; Shouling Wu; Xiujing Sun
Journal:  Obes Facts       Date:  2021-03-29       Impact factor: 3.942

2.  Aminotransferase levels as a prospective predictor for the development of metabolic syndrome in patients with schizophrenia.

Authors:  Eun Young Kim; Se Hyun Kim; Nam Young Lee; Jin Sang Yoon; Chul Eung Kim; Yong Sik Kim; Yong Min Ahn
Journal:  Psychopharmacology (Berl)       Date:  2014-05-13       Impact factor: 4.530

3.  Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

Authors:  Chan Wah-Kheong; Goh Khean-Lee
Journal:  Hepatol Int       Date:  2012-06-15       Impact factor: 6.047

4.  A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohort.

Authors:  M Srinivas; Vijaya Srinivasan; Madhu Bashini Mohan; Joy Varghese; Jayanthi Venkataraman
Journal:  Indian J Gastroenterol       Date:  2015-01-11

Review 5.  Prevalence of Nonalcoholic Fatty Liver Disease and Economy.

Authors:  Jin-Zhou Zhu; Yi-Ning Dai; Yu-Ming Wang; Qin-Yi Zhou; Chao-Hui Yu; You-Ming Li
Journal:  Dig Dis Sci       Date:  2015-05-28       Impact factor: 3.199

6.  Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study.

Authors:  Takuro Okamura; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

7.  Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults.

Authors:  Chao-Qun Yang; Long Shu; Shuai Wang; Jia-Jia Wang; Yu Zhou; Yu-Jie Xuan; Su-Fang Wang
Journal:  Nutrients       Date:  2015-06-15       Impact factor: 5.717

8.  Inverse association between hepatitis B virus infection and fatty liver disease: a large-scale study in populations seeking for check-up.

Authors:  Yuan-Lung Cheng; Yuan-Jen Wang; Wei-Yu Kao; Ping-Hsien Chen; Teh-Ia Huo; Yi-Hsiang Huang; Keng-Hsin Lan; Chien-Wei Su; Wan-Leong Chan; Han-Chieh Lin; Fa-Yauh Lee; Jaw-Ching Wu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

9.  Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China.

Authors:  Jun-Jie Liu; Yuan-Yuan Chen; Zeng-Nan Mo; Gui-Xiang Tian; Ai-Hua Tan; Yong Gao; Xiao-Bo Yang; Hai-Ying Zhang; Zhi-Xian Li
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

10.  Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men.

Authors:  Yuanliang Xie; Mengjie Wang; Youjie Zhang; Shijun Zhang; Aihua Tan; Yong Gao; Zhengjia Liang; Deyi Shi; Zhang Huang; Haiying Zhang; Xiaobo Yang; Zheng Lu; Chunlei Wu; Ming Liao; Yu Sun; Xue Qin; Yanling Hu; Li Li; Tao Peng; Zhixian Li; Xiaoli Yang; Zengnan Mo
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.